ANTHONY PETRACCA: Open Payments
NPI 1487636874 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 30 payments from 9 companies in 2025. Trend: 2023 $441 · 2024 $417 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $183 |
| GlaxoSmithKline, LLC. | 10 | $168 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Amgen Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $42 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $30 |
| Abbott Laboratories | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: QULIPTA, SHINGRIX, BEXSERO, MOUNJARO, FARXIGA, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, OTEZLA.
Industry payments across NY — which companies pay providers there.
